Healthcare Stocks
Recent market-moving SEC filings and news across healthcare companies, ranked by Wiseek's 1–10 importance score.
Browse Healthcare by industry
Healthcare covers these industries — each with its own live feed of market-moving events:
Biotech StocksMedical Device StocksPharmaceutical StocksHealth Tech StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a healthcare company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
$50M Private Placement Priced at $33.21, Led by Cormorant
Ascend Wellness Sets August 28 Vote on 1-for-10 to 1-for-50 Reverse Split to Enable Uplisting
GridAI Registers 9.9M Shares for Resale, Including New $8.5M July Placement, Extending Cash Runway to 18 Months
PacBio Director Christopher M. Smith Resigns Abruptly, No Reason Given
Inventiva wraps up EIB warrant restructuring with 15.7M new warrants at a €0.01 strike
Bone Biologics Closes $2.7M Placement, Below $3M Target; Warrants Add $6M Upside
Innovative Eyewear Raises $3M in Dilutive Warrant Exercise, Adds New Warrants
Bone Biologics closes $2.7M private placement with warrants, extending cash runway amid going concern
Innovative Eyewear Secures $3M Through Induced Warrant Exercise, Adds 6.6M New Warrants
Nyxoah Delivers €7.7M in Preliminary Q2 Revenue as CMS Proposes 12–15% Reimbursement Boost
CollPlant Registers 31M Shares for Resale from $2.6M Private Placement
Inventiva Finalizes EIB Warrant Restructuring, Eliminates Anti-Dilution Overhang
Bio-Techne Lays Out Equity Award Mechanics for Merck KGaA Buyout
Brookdale Reports Strong Q2 and June Occupancy Growth, Highest Net Move-Ins for 2026
Biodexa Sets July 29 Vote on 1-for-10,000 Reverse Split and £25M Share Authorization
Mitesco Registers 106.5M Shares for Resale — Potential Dilution Exceeds 80%
Nurix Q2 Loss Widens to $89.5M; Cash at $443.5M, Pro-Forma $1.14B with Roche Deal
Simulations Plus Q3 Revenue Climbs 7%, Net Income Swings to $3.6M; Altaris Merger at $18.50/Share Disclosed
CervoMed wraps up enrollment in Phase 2a neflamapimod trial for frontotemporal dementia
Nurix Q2 2026: $443.5M Cash, $89.5M Net Loss; Bexobrutideg Data and Roche Deal Progress
Pulmatrix Files S-4 for Reverse Merger with Eos SENOLYTIX, Issuing 75M Shares and Proposing Reverse Split
60 Degrees Pharma Submits Statistical Plan for Tafenoquine Trial, Eyes Priority Review Voucher
TuHURA Seeks Stockholder Nod for $5M Fee Share Issuance to Major Holder Affiliate
XWELL Sells XpresSpa and XpresTest for $13M, Shifts Focus to National Security
ImmuCell Q2 Sales Jump 12% to $7.2M, Six-Month Revenue Up 21%
Simulations Plus Posts Q3 EPS of 18c Amid Pending $375M Buyout
TruBridge Pays Off Credit Facility as IKS Health Merger Closes
TruBridge Merger with IKS Health Closes; Stock Delisted, Debt Paid Off
Shareholders greenlight a 2-million-share plan expansion and warrant issuance, deepening dilution for Traws Pharma
Simulations Plus Lays Out the Roadmap for Its $375M Altaris Buyout at $18.50/Share
Nurix Posts $443.5M Cash, Roche Deal Closing Nears with $700M Upfront
20/20 BioLabs Sees Q2 MCED Revenue Jump 30%+, Targets Medicare Coverage by 2028
Medline COO Stephen Miller to Retire for Health Reasons, Successor Search Underway
Tilray Launches Medical Cannabis in Panama, Expanding Latin American Footprint
ProPhase Labs Restates Q1 2026 Financials: Revenue Nearly Triples, Loss Narrows
Eplontersen Stumbles in Phase 3 ATTR-CM Trial, Setting Ionis Up for a Sharp Stock Decline
Medinotec Q1 Revenue Jumps 24% to $2.65M, U.S. Sales Surge 87%
EQT, Advent, KKR Circle Qiagen in Early Takeover Bid
Beyond Air finalizes a 1-for-20 reverse stock split, effective July 13, to regain Nasdaq compliance
Steel Partners Launches $16.75/Share All-Cash Bid for InMode, Topping CEO's Offer